September 26, 2014
Hilton Alexandria Old Town Hotel
The symposium will bring together representatives of academia, government and industry to review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The program will review IP issues for both diagnostics generally and companion diagnostics. It will also explore new collaborations and regulatory developments. BIO aims to inform industry and government alike on how to move the science forward in the current climate.
Who Should Attend?
This event is primarily geared towards patent practitioners in the life sciences, both in-house and in private practice. In-house regulatory affairs staff, licensing professionals, business development executives and regulatory agency staff seeking to understand the special premarketing and intellectual property challenges in this area would likewise benefit.